This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
Akshaya Patra: Impact at Scale
Rangan, V. Kasturi; Appleby, SarahCase HBS-517028-EAkshaya Patra, an Indian NGO, had set an ambitious goal of serving 5 million free meals daily to India's schoolchildren. Founded in 2000, Akshaya Patra had thus far opened 25 high-capacity kitchens in 10 different States to provide a midday meal to nearly 1.65 million school children every day. With 110 million children in 1 million schools eligible for a mandatory midday meal, there was room to grow. Shridhar Venkat, its CEO, had to devise a pla...Starting at €8.20
-
Communities In Schools (Atlanta): Innovating a College Program
Rangan, V. Kasturi; Applegate, Lynda M.; Lefort, AlexisCase HBS-823070-EEntrepreneurshipFrank Brown, CIS of Atlanta's new Black CEO, was keen to extend CIS's well-honed case management in schools program to youth in college. Founded 50 years ago by Bill Milliken, CIS, a network of 110 affiliates, had built a strong program of assisting and supporting youth in poverty schools to complete their high school education. CIS Atlanta's thrust which would be a new stretch for the network had the strong backing of the network's new national ...Starting at €8.20
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Global Teams That Work
Neeley, TsedalArticle HBS-R1510D-EMany companies today rely on employees around the world, leveraging their diversity and local expertise to gain a competitive edge. However, geographically dispersed teams face a big challenge: Physical separation and cultural differences can create social distance, or a lack of emotional connection, that leads to misunderstandings and mistrust. To help global team leaders manage effectively, the author shares her SPLIT framework for mitigating...Starting at €8.20
-
IESE ON. Lead yourself to lead
Ginebra, Gabriel; Reiche, Sebastian; Neeley, Tsedal; Rosanas, Josep Maria; Andreu i Civit, Rafael; Evangelia Demerouti; Clark, Dorie; IESE InsightDossier DOS-43-ELeadership and People ManagementWhat does it mean to be a good leader? Why should you want to be one, and what point are you at in your journey? Where, ultimately, do you want to go?
Leadership isn't a clearly marked path. It begins with you, with your knowledge of yourself and your ability to reflect on the world around you.
With this collection of articles, we provide the information you need to understand the kind of leader you are today, and the one you co...Starting at €15.00
-
Global Teams That Work (Spanish version)
Neeley, TsedalArticle HBS-R1510DStrategy(1) Structure. If a team is made up of groups with different views about their relative power, the leader should connect frequently with those who are farthest away and emphasize unity. (2) Process. Meeting processes should allow for informal interactions that build empathy. (3) Language. Everyone, regardless of language fluency, should be empowered to speak up. (4) Identity. Team members must be active cultural learners and teachers to understa...Starting at €8.20
-
IESE ON. Liderarte para liderar
Ginebra, Gabriel; Reiche, Sebastian; Neeley, Tsedal; Rosanas, Josep Maria; Andreu i Civit, Rafael; Evangelia Demerouti; Clark, Dorie; IESE InsightDossier DOS-43Leadership and People Management¿Qué significa ser un buen líder? ¿Para qué quiero serlo? ¿En qué punto estoy? ¿A dónde me gustaría llegar?
Sin duda, el liderazgo empieza por uno mismo. De ahí la importancia del autoconocimiento y la reflexión personal que te proponemos.
En esta colección de artículos, encontrarás la información que necesitas para reflexionar sobre el tipo de líder que eres hoy y el que podrías llegar a ser desarrollándote a ti y ayudando a tu...Starting at €15.00
-
De Egghead a Egghead.com (A)
Rangan, V. Kasturi; Bell, MarieCase HBS-507S15MarketingEn el transcurso de 12 meses en 1997 y 1998, Cerebrito alta dirección decidió cerrar sus 180 tiendas al por menor de ladrillo y mortero y se mueven a una tienda de electrónica. El caso describe la evolución de ese proceso, y el papel de su director general George Orban, y plantea preguntas sobre la viabilidad futura de la empresa.Starting at €8.20